Spruce Biosciences (NASDAQ:SPRB) Azioni, Quote.MetaTitle.unusual-options

SPRUCE BIOSCIENCES INC by Spruce Biosciences, Inc.

Spruce Biosciences Inc

Spruce Biosciences Inc Ordinary Shares

SPAREBANKEN 1 OSTLANDET by Sparebank 1 Ostlandet

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals

Alpha Cognition

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Alector

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

Climb Bio

Coya Therapeutics

Citius Oncology

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals

Entera Bio

Fate Therapeutics

Gain Therapeutics

Greenwich LifeSciences, Inc. - Common stock

Greenwich LifeSciences

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

Immix Biopharma

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

Opus Genetics

MDxHealth

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

Nkarta

Oncolytics Biotech

AVITA Medical

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics

Spruce Biosciences

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics

vTv Therapeutics Inc. - Class A Common Stock

vTv Therapeutics

Spruce Biosciences (SPRB) Previsione

Notizie

Utili

Quote.Nav.option-chain

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Comments

Spruce Biosciences Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO